Reuters logo
BRIEF-Oncology Venture Sweden Q2 pretax loss more than doubles to SEK 10.6 mln
August 25, 2017 / 11:46 AM / 4 months ago

BRIEF-Oncology Venture Sweden Q2 pretax loss more than doubles to SEK 10.6 mln

Aug 25 (Reuters) - ONCOLOGY VENTURE SWEDEN AB

* Q2 NET SALES SEK 1.6 MILLION VERSUS SEK 0 YEAR AGO

* Q2 PRETAX LOSS SEK 10.6 MILLION VERSUS LOSS SEK 5.2 MILLION YEAR AGO‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below